United States · FDA National Drug Code directory
Ganirelix Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70748-274_c0fdd470-a16f-41c4-9bfa-4240b6ff67e7
- Product NDC
- 70748-274
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Ganirelix Acetate
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240214
- Source listing expiry
- 20261231
Source-listed ingredients
- GANIRELIX ACETATE — 250 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TRAY in 1 CARTON (70748-274-01) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS · 70748-274-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →